Phagocyte chemiluminescence in pre-term infants

Area of Science:

• Neonatal immunology
• Respiratory medicine
• Cellular immunology

Background:

• Phagocyte function is vital for infection defense but implicated in infant respiratory distress syndrome (RDS) pathogenesis.
• Preterm infants exhibit deficient phagocyte function, increasing risks for both infection and RDS due to surfactant deficiency.
• Longitudinal studies on phagocyte function in preterm infants are scarce.

Purpose of the Study:

• To longitudinally assess phagocyte respiratory burst function in preterm infants.
• To investigate the association between phagocyte function and the development of RDS.
• To evaluate the impact of medical interventions on phagocyte function in this population.

Main Methods:

• Lucigenin-enhanced chemiluminescence was used to measure the respiratory burst of polymorphonuclear leucocytes and monocytes.
• Samples from 100 preterm infants were analyzed at 48- to 72-hour intervals during neonatal care unit admission.
• Multiple linear regression analysis was employed to identify influencing factors.

Main Results:

• Increased polymorphonuclear leucocyte chemiluminescence correlated with RDS and intermittent positive pressure ventilation.
• Gentamicin and penicillin use showed a slight, significant depression of chemiluminescence, even when accounting for RDS severity.
• Phagocyte function measurement via luminescence assays requires minimal blood volume.

Conclusions:

• Phagocyte function assessment using luminescence assays may help monitor RDS severity in preterm infants.
• While antibiotics had a minor impact, RDS and ventilation significantly influenced phagocyte function.
• Antioxidant capacity likely plays a crucial role in modulating tissue damage, independent of phagocyte function.